跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,437 条关于
“GPIIb/IIIa”
全部
8,437
临床试验
7,247
药物
123
机构
4
资讯
1,063
12个月前
CeleCor's Disaggpro Shows Positive Results in Phase 3 Trial for Pre-Hospital STEMI Treatment
2个月前
CeleCor Completes FDA Submission for Zalunfiban, a First-Point-of-Care Antiplatelet for STEMI Heart Attacks
2个月前
Shaanxi Micot Advances First-in-Class Dual-Target Anticoagulant MT1002 into Phase II Hemodialysis Trial
去年
Ultragenyx's UX111 Gene Therapy Shows Promise in Sanfilippo Syndrome Type A
去年
Keytruda Approved in China for Early-Stage NSCLC Treatment
3年前
Ultragenyx's UX111 Gene Therapy Shows Sustained Efficacy in MPS IIIA Patients
2年前
JCR Pharmaceuticals' JR-441 Receives Clearance for Phase I MPS IIIA Trial in Japan
4年前
Ultragenyx Acquires Global Rights to Abeona's Gene Therapy for Sanfilippo Syndrome Type A
去年
GC Biopharma and Novel Pharma Initiate Phase I Trial of GC1130A for Sanfilippo Syndrome Type A
5天前
Adjuvant Osimertinib Delivers Unprecedented 8-Year Overall Survival Benefit in Resected EGFR-Mutated NSCLC
第 1 页,共 107 页
上一页
下一页